Adalimumab weekly vs placebo
Frequency of serious adverse effects · participants with hidradenitis suppurativa
Adalimumab weekly showed no clear difference in frequency of serious adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
- RR 2 [0.38, 10.44]1 study · 102 participantsModerate